VEPESID Drug Patent Profile
✉ Email this page to a colleague
When do Vepesid patents expire, and when can generic versions of Vepesid launch?
Vepesid is a drug marketed by Strides Pharma and Corden Pharma and is included in two NDAs.
The generic ingredient in VEPESID is etoposide. There are eleven drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the etoposide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Vepesid
A generic version of VEPESID was approved as etoposide by HIKMA on July 17th, 1995.
Summary for VEPESID
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 90 |
Clinical Trials: | 227 |
Patent Applications: | 2,711 |
Formulation / Manufacturing: | see details |
DailyMed Link: | VEPESID at DailyMed |
Recent Clinical Trials for VEPESID
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Incyte Corporation | Phase 2 |
ADC Therapeutics | Phase 2 |
Joseph Tuscano | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for VEPESID
US Patents and Regulatory Information for VEPESID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Strides Pharma | VEPESID | etoposide | CAPSULE;ORAL | 019557-001 | Dec 30, 1986 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Strides Pharma | VEPESID | etoposide | CAPSULE;ORAL | 019557-002 | Dec 30, 1986 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Corden Pharma | VEPESID | etoposide | INJECTABLE;INJECTION | 018768-001 | Nov 10, 1983 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VEPESID
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Strides Pharma | VEPESID | etoposide | CAPSULE;ORAL | 019557-001 | Dec 30, 1986 | ⤷ Try a Trial | ⤷ Try a Trial |
Strides Pharma | VEPESID | etoposide | CAPSULE;ORAL | 019557-002 | Dec 30, 1986 | ⤷ Try a Trial | ⤷ Try a Trial |
Corden Pharma | VEPESID | etoposide | INJECTABLE;INJECTION | 018768-001 | Nov 10, 1983 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for VEPESID
See the table below for patents covering VEPESID around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Switzerland | 472403 | Verfahren zur Herstellung eines 4'-Demethyl-epipodophyllotoxins | ⤷ Try a Trial |
Brazil | 6683006 | ⤷ Try a Trial | |
Belgium | 687089 | ⤷ Try a Trial | |
Switzerland | 459257 | Verfahren zur Herstellung von 4'-Demethyl-epipodophyllotoxin | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |